The polynucleotide structure at the 3' end of turnip yellow mosaic virus (TYMV) RNA is recognized by at least four enzymes specific for transfer RNA (tRNA): valyl-tRNA synthetase, N-acyl aminoacyl-tRNA hydrolase (6, 7) , tRNA nucleotidyltransferase (3) , and the elongation factor EF-1 (Litvak et al., in press ). When the RNA extracted from the virion by the phenol procedure is incubated in the presence of adenosine 5'-triphosphate (ATP) and Escherichia coli tRNA nucleotidyltransferase, one molecule of adenosine 5'-monophosphate (AMP) is accepted at the 3' end of the 23s RNA molecule. When a 32P-ATP was used for this reaction, the nearest neighbor analyses showed that the last nucleotide in TYMV RNA is cytidylic acid which is preceded by a pyrimidine nucleotide, probably also a cytidylic acid (3) .
In order to gain more information on the tRNA-like structure of TYMV RNA, the 23s RNA molecule has been submitted to partial degradation by snake venom phosphodiesterase and checked for the acceptance of cytidine 5'-monophosphate (CMP) which is known to occur with -CCA-deprived tRNA. The incorporation of 32P-CMP also offers the possibility of determining the sequence of several nucleotides at the 3' end of the TYMV RNA molecule.
During the course of this work we observed that, under the action of an endonuclease present in commercial preparations of snake venom phosphodiesterase, a TYMV RNA fragment is produced that has a sedimentation constant of about 5s and bears the 3' end of the viral RNA.
The biological significance of the presence of a tRNA-like structure at the 3' end of TYMV RNA is unknown. The fact that this structure appears to be recognized by various enzymes involved in protein synthesis suggests that it might play a specific role in the translation of the viral genome (Haenni et al., in press). It also might be a signal for the initiation of viral RNA replication.
MATERIALS AND METHODS Materials. E. coli tRNA nucleotidyltransferase was purified as described previously (2) . E. coli valyl-tRNA ligase was a gift of M. Yaniv, and total E. coli aminoacyl-tRNA synthetases were prepared as reported elsewhere (4) . TYMV RNA was obtained from H. Duranton and from L. Bosch. To avoid degradation, the 23s RNA from both sources was kept as an ethanol suspension in the presence of bentonite. Snake venom phosphodiesterase and Tl ribonuclease were purchased from Worthington Biochemical Corp., and U2 ribonuclease was a gift of G. M. Barell. The radiochemicals a 32P-cytidine 5'-triphosphate (CTP), (400 mCi/mmole) and "1C-valine (108 mCi/mmole) were from the Commissariat a l'Energie Atomique, Saclay (France). 3H-CTP (1 mCi/jmole) and 3H-ATP (1 mCi/jimole) were purchased from Schwarz-BioResearch. Purified tRNA Phe was a gift from B. F. C. Clark.
3' terminal labeling of TYMV RNA. The incorporation of CMP into TYMV RNA was performed as described previously for the incorporation of AMP (3) . In a final volume of 0.2 ml the incubation mixture contained: 10 ;moles of tris(hydroxymethyl)-aminomethane (Tris)-hydrochloride (pH 8.5), 2 jinoles of MgCl2, 0.2 ymoles of f3-mercaptoethanol, 1 nmole of 3H-CTP or a 32P-CTP, 50 pmoles of 3' terminal -pCpC-deprived TYMV RNA, and 5 to 10 gg of E. coli tRNA nucleotidyltransferase.
After incubation, the RNA was precipitated with 5% cold trichloroacetic acid. After filtration on a Millipore filter and extensive washing with trichloroacetic acid, the radioactivity retained on the filter was determined by using a Nuclear-Chicago scintillation counter and Bray scintillation mixture.
Aminoacylation of TYMV RNA. When the incorporation of valine was tested, TYMV RNA was first preincubated in a mixture identical to that used for the tRNA nucleotidyltransferase assay, except that unlabeled ATP (0.1 Amole) was added.
After 30 min at 37 C the pH was adjusted to 7 by addition of 10 Amoles of sodium cacodylate, pH 5.5.
To this mixture 3 nmoles of '4C-valine and 1 Ag of pure E. coli valyl-tRNA synthetase or 50 jig of a preparation containing all aminoacyl-tRNA synthetases were added, and the incubations were pursued for 30 min more. After precipitation with cold 5% trichloroacetic and filtration on a membrane filter (Millipore Corp.) the radioactivity retained was determined. Snake venom phosphodiesterase treatment. The method used was similar to that described by Philipps et al. for tRNA (5) . TYMV RNA (2 to 5 mg) was incubated in a final volume of 1 ml in the presence of 50 ;Lmoles of glycine-NaOH (pH 8.5), 15 jumoles of MgC12, and 150 Mg of snake venom phosphodiesterase (Worthington). After 15 min at 37 C the incubation mixture was filtered on a Sephadex G-25 column (45 by 1 cm), on top of which was a 1-cm thick layer of silicic acid; the column had been previously equilibrated with 0.1 M acetate buffer, pH 4.5. Before the incubation mixture was put onto the Sephadex column, 5 show that the tRNA nucleotidyltransferasecatalyzed addition of nucleotides to TYMV RNA is similar to that observed with tRNA since in both cases CMP and AMP are incorporated.
The study of the esterification of phosphodiesterase-treated TYMV RNA by valine in the presence of E. coli valyl-tRNA synthetase has shown that after addition of only CMP the RNA is unable to accept the amino acid (Table 1) . After subsequent AMP addition, the extent of esterification of phosphodiesterase-treated RNA was about 15% lower than that observed with untreated RNA to which only AMP was added.
Nucleotide sequence at the 3' end of TYMV RNA. The results reported previously have shown that the terminal cytidylate in TYMV RNA is preceded by a pyrimidine nucleotide (3) . This nucleotide is also a cytidylate, as suggested by the fact that more than one molecule of CMP is incorporated into the phosphodiesterase-treated RNA. To obtain more information on this point, and at the same time on the nature of the third nucleotide, 32P-CMP-labeled RNA was submitted to alkaline hydrolysis, and the 2'-3' nucleotides formed were analyzed by two-dimensional thin-layer chromatography. It was found that only CMP and AMP contained 32p. This result clearly shows that the second nucleotide from the 3' end is a cytidylate as expected, and the third is an adenylate.
The nature of the fifth nucleotide was deduced from results published by Yot et al. (7) .
When 14C-valyl-RNA of TYMV was submitted to ribonuclease T1 digestion and the product was chromatographed on DEAEcellulose in the presence of 7 M urea, it was found that valine was attached to the 3' adenosine of a pentanucleotide; this means that the fifth nucleotide preceding the 3' terminal cytosine (or the sixth, preceding 3' adenosine after addition of AMP) is a guanylate. The sequence can then be written: ... pGpXpApCpC(pA).
The nature of the fourth nucleotide was determined by hydrolysis of 32P-CMP-labeled TYMV RNA with ribonucleases T1 and U2 and analysis of the labeled products. Since T, is specific for guanine and U2 for adenine, the product should be either Ap or XpAp. The use of pancreatic ribonuclease showed that X is a pyrimidine. To determine the nature of X, yeast tRNAPh , which has the 3' terminal structure pGpCpApCpCpA, was chosen to prepare the CpAp dinucleotide. Both XpAp and CpAp labeled in their 3' terminal phosphate were obtained by the same method. The comparison of their behavior on paper electrophoresis showed (Fig. 2) that they are identical and consequently that the sequence of five 3' terminal nucleotides of TYMV RNA is pGpCpApCpC. experiments are needed to clarify this point. The 3' fragment of TYMV RNA as substrate for the tRNA nucleotidyltransferase. During the sequence work which is reported in this paper it was found that incubation of TYMV RNA in the presence of commercial preparations of snake venom phosphodiesterase leads not only to the removal of the 3' terminal cytidylates but also to a fragmentation of the 23s RNA molecule. This is probably due to the presence in these preparations of a contaminating endonuclease. The interesting feature of this endonucleolytic splitting is that a fragment of about 5s from the 3' end representing approximately 2% of the total RNA molecule is liberated almost quantitatively without being degraded further. It was checked that under the same conditions the tRNA is not fragmented. Three different methods used for the characterization Gel filtration of phosphodiesterase-treated TYMV RNA. After action of snake phosphodiesterase (Worthington), the RNA was isolated and incubated in the presence of a32P-CTP and tRNA nucleotidyltransferase, and the product was filtered on a Sephadex G-100 column. The conditions are described in text. It was checked that after addition of CMP the 5s fragment was also an acceptor of AMP and of valine. 
